How Does Dulaglutide (Trulicity) Work? Mechanism of Action Explained

Direct Answer

Dulaglutide works by activating GLP-1 receptors, the same core mechanism shared across this medication class: stimulating insulin release when blood sugar is elevated, slowing gastric emptying, and reducing appetite. It's a single-target GLP-1 receptor agonist, dosed once weekly.

Real, Long-Term Evidence Behind It

Dulaglutide has one of the more extensive real-world cardiovascular outcome datasets in the GLP-1 class, backed by the REWIND trial, a large, long-term study specifically examining cardiovascular risk reduction. This gives it a genuinely well-established safety and outcome track record, even though it hasn't kept pace with newer medications on average weight-loss results.

How It Compares to Newer Medications

As a single-target GLP-1 medication approved primarily for diabetes management, dulaglutide generally shows more modest average weight loss in trials compared to tirzepatide or semaglutide at weight-management doses. It remains a well-established, thoroughly studied option specifically for blood sugar and cardiovascular risk management.

Bottom Line

Dulaglutide's mechanism is the same core GLP-1 pathway as other medications in this class, with one of the strongest long-term cardiovascular outcome track records available.

References

• Trulicity Prescribing Information (FDA)
• The REWIND Trial: Dulaglutide's Cardiovascular Evidence

Related Resources

• Dulaglutide Medication Guide
• The REWIND Trial: Dulaglutide's Cardiovascular Evidence

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. The information on DietApp.com is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.